Adjuvant IFN alpha2 therapy of melanoma

Lancet. 1998 Jun 27;351(9120):1901-3. doi: 10.1016/S0140-6736(05)78608-6.
No abstract available

Publication types

  • Comment

MeSH terms

  • Antineoplastic Agents / therapeutic use*
  • Clinical Trials as Topic
  • Disease-Free Survival
  • Humans
  • Interferon alpha-2
  • Interferon-alpha / therapeutic use*
  • Melanoma / mortality
  • Melanoma / secondary
  • Melanoma / therapy*
  • Prognosis
  • Randomized Controlled Trials as Topic
  • Recombinant Proteins
  • Skin Neoplasms / mortality
  • Skin Neoplasms / pathology
  • Skin Neoplasms / therapy*

Substances

  • Antineoplastic Agents
  • Interferon alpha-2
  • Interferon-alpha
  • Recombinant Proteins